1-20 of 69
Rohtesh S. Mehta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Post-Transplant Cyclophosphamide (PTCy) with or without MMF in the Prevention of De Novo and Progressive / Relapsing Chronic Graft-Versus-Host Disease after HLA-Matched Donor Transplant

Rima M. Saliba, Curtis Marcoux, Amin Alousi, Gabriela Rondon, Julianne Chen, May Daher, MD, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Rohtesh S. Mehta
Journal: Blood
Blood (2023) 142 (Supplement 1): 2188.
https://doi.org/10.1182/blood-2023-188108
Published: 2023
Journal Articles

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

Rahul Banerjee, Andrew J. Cowan, Marivel Chavez-Ortega, Paul A Carpenter, Masumi Ueda Oshima, Rachel B. Salit, Phuong T Vo, Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher T. Su
Journal: Blood
Blood (2023) 142 (Supplement 1): 2386.
https://doi.org/10.1182/blood-2023-174554
Published: 2023
Journal Articles

Combined Effect of Unrelated Donor Age and HLA Peptide-Binding Motifs (PBM) Match Status on HCT Outcomes

Rohtesh S. Mehta, Effie W. Petersdorf, Stephen R. Spellman, Stephanie J. Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 1045.
https://doi.org/10.1182/blood-2023-173887
Published: 2023
Journal Articles

MMF Is Associated with Worse OS in CMV Seropositive AML Patients Undergoing MUD HCT with Calcineurin-Inhibitor-Based Gvhd Prophylaxis

Rima M. Saliba, Stephanie J. Lee, Paul A Carpenter, Catherine J. Lee, Geoffrey R Hill, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Rohtesh S. Mehta
Journal: Blood
Blood (2023) 142 (Supplement 1): 236.
https://doi.org/10.1182/blood-2023-186402
Published: 2023
Journal Articles

Efficacy and Safety of Gilteritinib Vs. Sorafenib As Post-Transplant Maintenance in Patients with FLT3-ITD Acute Myeloid Leukemia

Jason Yeh, Rima M. Saliba, Christopher Wang, Zhou Fang, Bradley Figgins, Sairah Ahmed, Musa Yilmaz, Naval Daver, Rohtesh S. Mehta, Gheath Alatrash, David Marin, Uday R Popat, Richard E Champlin, Elizabeth J Shpall, Betul Oran
Journal: Blood
Blood (2022) 140 (Supplement 1): 7686–7688.
https://doi.org/10.1182/blood-2022-165780
Published: 2022
Journal Articles

Precision-Engineered Cell Therapy Orca-T Demonstrates High Relapse-Free Survival at 1 Year While Reducing Graft-Versus-Host Disease and Toxicity

Caspian Oliai, Rasmus T Hoeg, Anna Pavlova, Arpita Gandhi, Lori Muffly, Rohtesh S. Mehta, Samer A Srour, Edmund K. Waller, Robert Lowsky, Sagar S. Patel, Bhagirathbhai Dholaria, Carlos Bachier, Jeremy M. Pantin, Amandeep Salhotra, Joseph P. McGuirk, Nathaniel B Fernhoff, J Scott McClellan, Mehrdad Abedi, Robert S. Negrin, Everett H Meyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 654–656.
https://doi.org/10.1182/blood-2022-165654
Published: 2022
Journal Articles

Transplant Outcomes for TP53 AML and MDS in a Contemporary Era

Gonca Ozcan, Uday R Popat, Partow Kebriaei, Amin M Alousi, Gheath Alatrash, Qaiser Bashir, Rohtesh S. Mehta, Jeremy L. Ramdial, Gabriela Rondon, Elizabeth J Shpall, Richard E Champlin, Betul Oran
Journal: Blood
Blood (2022) 140 (Supplement 1): 10620–10621.
https://doi.org/10.1182/blood-2022-157039
Published: 2022
Journal Articles

HLA B-Leader Mismatch Is Associated with Poor Outcomes in NIMA/NIPA Mismatched Haploidentical Sibling Donor HCT

Rohtesh S. Mehta, Rima M. Saliba, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R. Popat, Muzaffar H. Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A. Srour, Katy Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Kai Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 4880–4881.
https://doi.org/10.1182/blood-2022-158689
Published: 2022
Journal Articles

Efficacy of Azacitidine Post-Transplant Maintenance for FLT3-Negative Acute Myeloid Leukemia and Myelodysplastic Syndrome

Oren Pasvolsky, Rima M. Saliba, Uday R Popat, Amin M Alousi, Rohtesh S. Mehta, Jason Yeh, Gheath Alatrash, Adeel Masood, Jeremy L. Ramdial, Gabriela Rondon, Partow Kebriaei, Richard E Champlin, Elizabeth J Shpall, Betul Oran
Journal: Blood
Blood (2022) 140 (Supplement 1): 10550–10551.
https://doi.org/10.1182/blood-2022-159336
Published: 2022
Journal Articles

Mother Vs Father Haploidentical Donor for T Cell-Replete HCT with Ptcy Prophylaxis

Rohtesh S. Mehta, Rima M. Saliba, Amin M Alousi, Gheath Alatrash, Qaiser Bashir, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R Popat, Muzaffar H Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A Srour, Katy Rezvani, Richard E Champlin, Elizabeth J Shpall, Kai Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 10530–10531.
https://doi.org/10.1182/blood-2022-166472
Published: 2022
Journal Articles

A Phase II Clinical Trial of "Off-the-Shelf" NK Cells with Allogeneic Stem Cell Transplantation to Decrease Disease Relapse in Patients with High-Risk Myeloid Malignancies

Jeremy L. Ramdial, Lorlyn Clemente-Sevilla, Doris Soebbing, Bouthaina S. Dabaja, Peter F Thall, Gheath Alatrash, Amin M Alousi, Rohtesh S. Mehta, Uday R Popat, Partow Kebriaei, Betul Oran, Katy Rezvani, Elizabeth J Shpall, Richard E Champlin
Journal: Blood
Blood (2022) 140 (Supplement 1): 7484–7485.
https://doi.org/10.1182/blood-2022-170663
Published: 2022
Journal Articles

Son Vs Daughter Haploidentical Donor for T Cell-Replete HCT with Ptcy Prophylaxis

Rohtesh S. Mehta, Rima M. Saliba, Amin M Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R Popat, Muzaffar H Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A Srour, Katy Rezvani, Richard E Champlin, Elizabeth J Shpall, Kai Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 7649–7650.
https://doi.org/10.1182/blood-2022-166381
Published: 2022
Journal Articles

Phase II Trial of Venetoclax (Ven) in Combination with Azacitidine (AZA) As Maintenance Therapy for High-Risk Acute Leukemia Following Allogeneic Stem Cell Transplantation (SCT)

Betul Oran, Richard E Champlin, Peter F Thall, Jessica M McCarty, Wen Zhang, David Marin, Rohtesh S. Mehta, Amin M Alousi, Gheath Alatrash, Uday R Popat, Hagop Kantarjian, Qaiser Bashir, Elizabeth J Shpall, Marina Konopleva
Journal: Blood
Blood (2022) 140 (Supplement 1): 10561–10562.
https://doi.org/10.1182/blood-2022-159312
Published: 2022
Journal Articles

Long-Term Outcomes of Acute Myeloid Leukemia Following Allogeneic Stem-Cell Transplantation after Decitabine and Venetoclax: Subgroup Analysis of a Phase II Trial

Abhishek Maiti, Courtney D. DiNardo, Maro Ohanian, Naveen Pemmaraju, Naval Daver, Gautam Borthakur, Farhad Ravandi, Ghayas C. Issa, Guillermo Garcia-Manero, Nitin Jain, Tapan M. Kadia, Lucia Masarova, William G. Wierda, Musa Yilmaz, Yesid Alvarado, Elias Jabbour, Nicholas Short, Koichi Takahashi, Sanam Loghavi, Keyur P. Patel, Kathryn Montalbano, Sherry A. Pierce, Carol A. Bivins, Rohtesh S. Mehta, Gheath Alatrash, Uday R Popat, Partow Kebriaei, Betul Oran, Elizabeth J Shpall, Richard E Champlin, Hagop Kantarjian, Marina Konopleva
Journal: Blood
Blood (2022) 140 (Supplement 1): 7725–7728.
https://doi.org/10.1182/blood-2022-169896
Published: 2022
Journal Articles

A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule and Dose of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Qaiser Bashir, Peter F. Thall, Dawen Sui, Jeremy L. Ramdial, Samer A. Srour, Rohtesh S. Mehta, Uday R. Popat, Yago Nieto, Neeraj Saini, Partow Kebriaei, Elisabet E. Manasanch, Hans C. Lee, Gregory P. Kaufman, Sheeba K Thomas, Krina K. Patel, Robert Z. Orlowski, Cristina G. Knape, Jitesh D. Kawedia, Richard E. Champlin, Elizabeth J. Shpall, Xiaoqian Liu, Muzaffar H. Qazilbash
Journal: Blood
Blood (2021) 138 (Supplement 1): 3941.
https://doi.org/10.1182/blood-2021-149807
Published: 2021
Journal Articles

Incidence and Outcomes of Toxoplasma Reactivation in Patients with Hematologic Diseases after Allogeneic Hematopoietic Stem Cell Transplantation

Taha Al-Juhaishi, Alexandre Elias Malek, Denái R. Milton, Jeremy L. Ramdial, May Daher, Amanda L. Olson, Samer A. Srour, Gheath Alatrash, Betul Oran, Rohtesh S. Mehta, Issa F. Khouri, Qaiser Bashir, Nina Shah, Stefan O. Ciurea, Gabriela Rondon, Farzaneh Maadani, Chitra Hosing, David Marin, Partow Kebriaei, Katayoun Rezvani, Yago Nieto, Paolo Anderlini, Amin M. Alousi, Muzaffar H. Qazilbash, Uday R. Popat, Richard E. Champlin, Elizabeth J. Shpall, Victor Mulanovich, Sairah Ahmed
Journal: Blood
Blood (2021) 138 (Supplement 1): 1779.
https://doi.org/10.1182/blood-2021-151474
Published: 2021
Journal Articles

Optimizing Myeloablative Fractionated Busulfan, Fludarabine and Thiotepa Regimen: Results of Two Parallel Cohorts in a Phase 2 Prospective Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Katayoun Rezvani, Muzaffar H. Qazilbash, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1802.
https://doi.org/10.1182/blood-2021-146655
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Hagop Kantarjian, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2021-146245
Published: 2021
Journal Articles

Orca-T Results in High Gvhd-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies: Results of a Single Center Phase 2 and a Multicenter Phase 1b Study

Rasmus T. Hoeg, Anna Moroz, Arpita Gandhi, Lori Muffly, Parveen Shiraz, Caspian Oliai, Rohtesh S. Mehta, Samer A. Srour, Joseph P. McGuirk, Edmund K. Waller, Sally Arai, Laura J. Johnston, Robert Lowsky, Andrew R. Rezvani, Wen-Kai Weng, David B. Miklos, Matthew J. Frank, John Tamaresis, Ying Lu, Vaibhav Agrawal, Nathaniel B Fernhoff, Gerhard Bauer, Amy Putnam, J Scott McClellan, Bronwen E. Shaw, Mehrdad Abedi, Robert S. Negrin, Everett H Meyer
Journal: Blood
Blood (2021) 138 (Supplement 1): 98.
https://doi.org/10.1182/blood-2021-154191
Published: 2021
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial

Uday R. Popat, Roland Bassett, Peter F. Thall, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Naval Daver, Farhad Ravandi, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson, Rohtesh S. Mehta
Journal: Blood
Blood (2021) 138 (Supplement 1): 556.
https://doi.org/10.1182/blood-2021-152450
Published: 2021